Medical ethics during the war on terror

The lede:

Medical students get a failing grade on their knowledge of physicians’ ethical obligations during wartime, according to a new study authored by a team of Harvard Medical School physicians.

The authors said their study, published in October in the International Journal of Health Services, should prompt medical schools to educate future doctors more thoroughly on the ethical questions they could face in an age of terror and torture.

But experts said that although medical curricula could cover military medical ethics, such instruction should be folded into discussions about the broader problem of dual loyalty — when doctors’ advocacy for the patient conflicts with other institutional or societal objectives.

The whole shebang.

Saying no to embryos?

The lede:

Two teams of scientists simultaneously announced they have reprogrammed human skin cells to obtain pluripotency, the characteristic hailed in embryonic stem cells as having the potential for therapeutic breakthroughs in areas ranging from Parkinson’s disease to diabetes.

Scientists in Japan and Wisconsin created the so-called induced pluripotent cells by introducing different combinations of genes into skin cells that are normally switched off after embryonic cells differentiate into various cell types. The results were published last month in Cell and Nature, respectively.

Researchers, ethicists, religious leaders and politicians hailed the findings, saying the innovative work could allow society to reap scientific and medical benefits of stem cell research without destroying embryos.

The whole shebang.

Size matters

The lede:

Large physician groups have long had a head start on solo and small practices in the medical marketplace because they can negotiate better health plan contracts. Now, a rising tide of evidence indicates that size also confers a quality advantage.

Researchers admit that the medical literature emerging on the relationship between group size and quality is far from a slam dunk. They argue, however, that bigger physician groups can pool capital to pay for electronic medical records systems and other quality initiatives that help them more reliably deliver guideline-based care.

On the opposite end of the spectrum, a small but growing movement of doctors is experimenting with a leaner model of medicine that they say improves the financial viability of solo and small-group practice and, most importantly, improves patient care.

The whole shebang.

Redesigning informed consent

The lede:

Toni Cordell’s surgery would be “an easy repair,” her doctor said. Embarrassed at being a slow reader, she signed the informed-consent papers she was given without understanding them.

She said no one, including her doctor, explained the procedure in detail beforehand or uttered the word “hysterectomy.” Cordell didn’t discover the nature of her operation until months after surgery when an office nurse inquired about her recovery.

Cordell’s story of being bewildered by medical-legal jargon is not unique. According to a 2005 National Quality Forum report, between 60% and 70% of patients do not read or understand informed-consent documents and nearly half cannot recall the exact nature of the operation to be performed.

Now a growing number of hospitals and physicians are moving to redesign informed-consent protocols. They are using new computer technology and education techniques to improve safety and ensure that patients understand a surgery’s risks and benefits. Informed consent is a process, they say, not a piece of paper.

The whole shebang.

Regulating drug industry gifts to physicians

The lede:

Thirteen states this year have seen legislative proposals aimed at limiting financial relationships between physicians and drugmakers. Most bills failed to pass, due to heavy pressure from pharmaceutical lobbyists, experts said, but new efforts are afoot.

The latest proposals include a Michigan bill that would make that state the second in the nation after Minnesota to place a limit — $100 — on the total value of gifts a drugmaker can give a physician in a year. Michigan and Massachusetts are considering so-called sunshine laws requiring drug companies to publicly disclose any gifts, payments, subsidies or incentives worth more than $25.

The whole shebang.

Who’s a good doctor?

The lede:

The Robert Wood Johnson Foundation is pouring $15.9 million into a new effort to give doctors and the public a more accurate assessment of physician performance.

The plan is to combine national Medicare and private health plan claims data and then use the data for public reporting of physician performance on quality and cost measures. Reporting in select areas is set for 2010.

The initiative comes on top of criticism that the nation’s dozens of quality measurement and reporting efforts are redundant or rely on widely varying metrics. For example, a 2005 Institute of Medicine report on performance measurement called for a new office in Health and Human Services to coordinate and fund the development of metrics for pay-for-performance and public reporting programs.

The whole shebang.

Doctors and executions

My stories for American Medical News are now freely available for about 90 days after they go live on the Web site. So, I’ve decided to start posting the first few grafs and links to the stories here in case you’re interested in reading.

The beat — medical ethics, patient safety and health care quality — is pretty interesting because quite a few of the stories are of great interest to many people who are not physicians. A great example is this story.

The lede:

The only state medical board in the country with policy declaring physician participation in executions “a departure from the ethics of the medical profession” and grounds for discipline was rebuked in state court late last month.

Wake County (N.C.) Superior Court Judge Donald W. Stephens ruled that the North Carolina Medical Board overstepped its authority in threatening to punish doctors who take an active role in the death chamber. But executions in the state will not resume due to the pending cases of five North Carolina death-row inmates on lethal injection protocols.

Read the whole shebang.

News tease

American Medical News — the weekly newspaper for which I do reporting on medical ethics, health care quality and patient safety — is still behind a password-protected firewall. However, the Web site has gone to a Salon-like model where the reader can see the first few paragraphs of a story for free, before being prompted to login or pay up.

So I’ve decided to post links to those stories over on my journalism page. If nothing else, these teasers should give you a flavor for the kind of work I’m doing. For example, my most recently published articles focus on what the November elections mean for stem-cell research funding and how hospitals are moving toward more permissive policies on cell phone use.

New digs

As of mid-July, my reign of terror at Insurance Journal will officially come to an end. I’ve enjoyed insurance reporting and hope to continue doing it on a freelance basis, but I’m moving on to new digs. American Medical News is “the newspaper for America’s physicians,” at least the ones who are members of the American Medical Association. Here is some general information about the newspaper and here’s a “descriptive profile.” Unfortunately, access to the Web site is restricted to members of the AMA, so I’m not sure how or whether I’ll be able to make my articles available on kevin.oreilly.net.

I’ll work as a reporter covering the medical ethics and patient safety beat in the professional issues section. I look forward to working with the section’s editor, Bonnie Booth, who was a journalism instructor of mine at Columbia College Chicago. Aside from the challenge and excitement of tackling a new beat, a big plus is that I’ll be leaving home and working in a newsroom every day.

Working from a home office as an editor for IJ has definitely had its advantages, but I think that my professional and personal development was beginning to suffer a little bit from being home-bound most days. In two months, I may long for the good ol’ days when I could work in shorts and didn’t have to talk to anyone before noon if I didn’t feel like it. I think that on balance, though, I’ll benefit from the new downtown (OK, River North to be exact) work environment.

Another big plus about the new gig is that I’ll be able to focus solely on reporting. I think I’ve handled the reporting/editing juggling act well at IJ, but I haven’t really liked it all that much. So as you can tell, my reasons for leaving IJ really are personal. It’s staffed by a bunch of kind, hard-working and generous people, led by smart people with real vision, and the magazine itself serves a real need in the marketplace.

If my experience with AMNews is half as good as my tenure at IJ, I’ll have really lucked out. Of course, I’ve had more than my fair share of luck already. Thanks to the generosity and confidence of my journalism mentors and colleagues, I’ve prospered where so many beginners struggle. And thanks to the support of my wife and my family, I know that regardless of my professional travails, love is … love.